Stay informed with the latest litigation news. Explore now

Millennium Pharmaceuticals competitive analysis

Latest publications and patents of Millennium Pharmaceuticals New

Explore the latest publications and patents granted to Millennium Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Millennium Pharmaceuticals

May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyGranted And Under Opposition
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple MyelomaRevoked
Jan 24, 2018Derivatives Of 1-Amino-2-Cyclopropylethylboronic AcidNo Opposition Filed Within Time Limit
Jan 10, 2018Heteroaryl Compounds Useful As Inhibitors Of Sumo Activating EnzymeNo Opposition Filed Within Time Limit
Jul 12, 2017Formulation For Anti- Alpha4Beta7 AntibodyOpposition Rejected
Jul 12, 2017Formulation For Anti- 4 7 AntibodyRevoked

Explore Millennium Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody1
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
Jul 12, 2017Formulation For Anti- 4 7 Antibody2
Jul 12, 2017Formulation For Anti- Alpha4Beta7 Antibody1

Latest PTAB cases involving Millennium Pharmaceuticals New

Discover the latest PTAB cases involving Millennium Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Top competitors of Millennium Pharmaceuticals

Top competitors of Millennium Pharmaceuticals based on patent oppositions.